Corvus Pharmaceuticals (CRVS)
Develops immune-disease and cancer therapies centered on soquelitinib.
$12.54
vs last close−0.90 (−6.70%)
Something off on this page? Send us feedback.
Next report
Nov 3, 26
in 41 days
EPS estimate
−$0.21
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.18−$0.13−$0.10−$0.12−$0.15−$0.15−$0.19Pending
Estimate−$0.12−$0.13−$0.13−$0.14−$0.14−$0.14−$0.16−$0.21
Surprise−50.0%0.0%+23.1%+14.3%−7.1%−7.1%−19.4%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported———————Pending
Estimate————$775.0K———
Surprise————————
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.25 | — | — |
| Sep 2027 | −$0.24 | — | — |
| Jun 2027 | −$0.25 | — | — |
| Mar 2027 | −$0.23 | — | — |
| Dec 2026 | −$0.21 | — | — |
| Nov 2026 | −$0.21 | — | — |
| Aug 2026 | −$0.16 | −$0.19 | −19.4% |
| May 2026 | −$0.14 | −$0.15 | −7.1% |
| Mar 2026 | −$0.14 | −$0.15 | −7.1% |
| Nov 2025 | −$0.14 | −$0.12 | +14.3% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| Apr 2021 | |||
| Mar 2021 | |||
| Oct 2020 | |||
| Jul 2020 | |||
| Apr 2020 | |||
| Mar 2020 | |||
| Oct 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Dec 2015 | |||
| Mar 2016 | |||
| Jun 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.25 | — | — | $4.2M | — | — | — |
| Sep 2027 | −$0.24 | — | — | $3.1M | — | — | — |
| Jun 2027 | −$0.25 | — | — | $0 | — | — | — |
| Mar 2027 | −$0.23 | — | — | $0 | — | — | — |
| Dec 2026 | −$0.21 | — | — | $0 | — | — | — |
| Nov 3, 2026 | −$0.21 | — | — | $0 | — | — | — |
| Aug 6, 2026 | −$0.16 | −$0.19 | −19.4% | — | — | — | +0.4% |
| May 7, 2026 | −$0.14 | −$0.15 | −7.1% | — | — | — | +6.6% |
| Mar 12, 2026 | −$0.14 | −$0.15 | −7.1% | $775.0K | — | — | −4.3% |
| Nov 4, 2025 | −$0.14 | −$0.12 | +14.3% | — | — | — | −1.4% |
| Aug 7, 2025 | |||||||
| May 8, 2025 | |||||||
| Mar 25, 2025 | |||||||
| Nov 12, 2024 | |||||||
| Aug 6, 2024 | |||||||
| May 6, 2024 | |||||||
| Mar 19, 2024 | |||||||
| Nov 7, 2023 | |||||||
| Aug 8, 2023 | |||||||
| May 8, 2023 | |||||||
| Mar 28, 2023 | |||||||
| Nov 3, 2022 | |||||||
| Aug 8, 2022 | |||||||
| May 5, 2022 | |||||||
| Mar 10, 2022 | |||||||
| Nov 1, 2021 | |||||||
| Aug 2, 2021 | |||||||
| Apr 29, 2021 | |||||||
| Mar 25, 2021 | |||||||
| Oct 29, 2020 | |||||||
| Jul 30, 2020 | |||||||
| Apr 30, 2020 | |||||||
| Mar 5, 2020 | |||||||
| Oct 29, 2019 | |||||||
| Aug 1, 2019 | |||||||
| May 9, 2019 | |||||||
| Mar 7, 2019 | |||||||
| Nov 1, 2018 | |||||||
| Aug 2, 2018 | |||||||
| May 3, 2018 | |||||||
| Mar 1, 2018 | |||||||
| Nov 2, 2017 | |||||||
| Aug 3, 2017 | |||||||
| May 4, 2017 | |||||||
| Mar 10, 2017 | |||||||
| Nov 3, 2016 | |||||||
| Aug 4, 2016 | |||||||
| May 6, 2016 | |||||||
| Dec 31, 2015 | |||||||
| Mar 22, 2016 | |||||||
| Jun 30, 2015 |